These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 14729600

  • 1. Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor.
    Rofstad EK, Mathiesen B, Galappathi K.
    Cancer Res; 2004 Jan 01; 64(1):13-8. PubMed ID: 14729600
    [Abstract] [Full Text] [Related]

  • 2. The tumor bed effect: increased metastatic dissemination from hypoxia-induced up-regulation of metastasis-promoting gene products.
    Rofstad EK, Mathiesen B, Henriksen K, Kindem K, Galappathi K.
    Cancer Res; 2005 Mar 15; 65(6):2387-96. PubMed ID: 15781654
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia promotes lymph node metastasis in human melanoma xenografts by up-regulating the urokinase-type plasminogen activator receptor.
    Rofstad EK, Rasmussen H, Galappathi K, Mathiesen B, Nilsen K, Graff BA.
    Cancer Res; 2002 Mar 15; 62(6):1847-53. PubMed ID: 11912164
    [Abstract] [Full Text] [Related]

  • 4. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J, Rabbani SA, Shibata HR, Brodt P.
    J Clin Invest; 1995 May 15; 95(5):2096-103. PubMed ID: 7537755
    [Abstract] [Full Text] [Related]

  • 5. Limitations of dynamic contrast-enhanced MRI in monitoring radiation-induced changes in the fraction of radiobiologically hypoxic cells in human melanoma xenografts.
    Benjaminsen IC, Melås EA, Mathiesen BS, Rofstad EK.
    J Magn Reson Imaging; 2008 Nov 15; 28(5):1209-18. PubMed ID: 18972344
    [Abstract] [Full Text] [Related]

  • 6. Involvement of MAPK pathway in hypoxia-induced up-regulation of urokinase plasminogen activator receptor in a human prostatic cancer cell line, PC3MLN4.
    Lee KH, Choi EY, Hyun MS, Kim JR.
    Exp Mol Med; 2004 Feb 29; 36(1):57-64. PubMed ID: 15031672
    [Abstract] [Full Text] [Related]

  • 7. Antisense oligodeoxynucleotides for urokinase-plasminogen activator receptor have anti-invasive and anti-proliferative effects in vitro and inhibit spontaneous metastases of human melanoma in mice.
    D'Alessio S, Margheri F, Pucci M, Del Rosso A, Monia BP, Bologna M, Leonetti C, Scarsella M, Zupi G, Fibbi G, Del Rosso M.
    Int J Cancer; 2004 May 20; 110(1):125-33. PubMed ID: 15054877
    [Abstract] [Full Text] [Related]

  • 8. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.
    Khatib AM, Nip J, Fallavollita L, Lehmann M, Jensen G, Brodt P.
    Int J Cancer; 2001 Feb 01; 91(3):300-8. PubMed ID: 11169951
    [Abstract] [Full Text] [Related]

  • 9. Both increased stability and transcription contribute to the induction of the urokinase plasminogen activator receptor (uPAR) message by hypoxia.
    Maity A, Solomon D.
    Exp Cell Res; 2000 Mar 15; 255(2):250-7. PubMed ID: 10694440
    [Abstract] [Full Text] [Related]

  • 10. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression.
    Graham CH, Forsdike J, Fitzgerald CJ, Macdonald-Goodfellow S.
    Int J Cancer; 1999 Feb 09; 80(4):617-23. PubMed ID: 9935166
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of urokinase-type plasminogen activator receptor induces apoptosis in melanoma cells by activation of p53.
    Besch R, Berking C, Kammerbauer C, Degitz K.
    Cell Death Differ; 2007 Apr 09; 14(4):818-29. PubMed ID: 17110957
    [Abstract] [Full Text] [Related]

  • 12. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours.
    Rofstad EK, Måseide K.
    Int J Radiat Biol; 1999 Nov 09; 75(11):1377-93. PubMed ID: 10597912
    [Abstract] [Full Text] [Related]

  • 13. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
    Taniguchi T, Kakkar AK, Tuddenham EG, Williamson RC, Lemoine NR.
    Cancer Res; 1998 Oct 01; 58(19):4461-7. PubMed ID: 9766679
    [Abstract] [Full Text] [Related]

  • 14. Intraperitoneal injection of a hairpin RNA-expressing plasmid targeting urokinase-type plasminogen activator (uPA) receptor and uPA retards angiogenesis and inhibits intracranial tumor growth in nude mice.
    Gondi CS, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS.
    Clin Cancer Res; 2007 Jul 15; 13(14):4051-60. PubMed ID: 17634529
    [Abstract] [Full Text] [Related]

  • 15. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD, Tomaso H, Mengele K, Schilling D, Bayer C, Stadler P, Schmitt M, Molls M.
    Oncol Rep; 2007 May 15; 17(5):1259-68. PubMed ID: 17390074
    [Abstract] [Full Text] [Related]

  • 16. pO₂ fluctuation pattern and cycling hypoxia in human cervical carcinoma and melanoma xenografts.
    Ellingsen C, Ovrebø KM, Galappathi K, Mathiesen B, Rofstad EK.
    Int J Radiat Oncol Biol Phys; 2012 Jul 15; 83(4):1317-23. PubMed ID: 22270159
    [Abstract] [Full Text] [Related]

  • 17. Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts.
    Gaustad JV, Simonsen TG, Andersen LMK, Rofstad EK.
    J Transl Med; 2017 Nov 28; 15(1):241. PubMed ID: 29183378
    [Abstract] [Full Text] [Related]

  • 18. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 19. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
    Øvrebø KM, Gulliksrud K, Mathiesen B, Rofstad EK.
    Int J Radiat Oncol Biol Phys; 2011 Sep 01; 81(1):255-61. PubMed ID: 21816291
    [Abstract] [Full Text] [Related]

  • 20. DU145 human prostate carcinoma invasiveness is modulated by urokinase receptor (uPAR) downstream of epidermal growth factor receptor (EGFR) signaling.
    Mamoune A, Kassis J, Kharait S, Kloeker S, Manos E, Jones DA, Wells A.
    Exp Cell Res; 2004 Sep 10; 299(1):91-100. PubMed ID: 15302576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.